IBDEI20M ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32164,1,4,0)
 ;;=4^N91.2
 ;;^UTILITY(U,$J,358.3,32164,2)
 ;;=^5015904
 ;;^UTILITY(U,$J,358.3,32165,0)
 ;;=N92.1^^126^1649^2
 ;;^UTILITY(U,$J,358.3,32165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32165,1,3,0)
 ;;=3^Breakthrough Bleeding
 ;;^UTILITY(U,$J,358.3,32165,1,4,0)
 ;;=4^N92.1
 ;;^UTILITY(U,$J,358.3,32165,2)
 ;;=^5015909
 ;;^UTILITY(U,$J,358.3,32166,0)
 ;;=N92.4^^126^1649^3
 ;;^UTILITY(U,$J,358.3,32166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32166,1,3,0)
 ;;=3^Excessive Bleeding in the Premenopausal Period
 ;;^UTILITY(U,$J,358.3,32166,1,4,0)
 ;;=4^N92.4
 ;;^UTILITY(U,$J,358.3,32166,2)
 ;;=^5015911
 ;;^UTILITY(U,$J,358.3,32167,0)
 ;;=N92.6^^126^1649^4
 ;;^UTILITY(U,$J,358.3,32167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32167,1,3,0)
 ;;=3^Irregular Menses
 ;;^UTILITY(U,$J,358.3,32167,1,4,0)
 ;;=4^N92.6
 ;;^UTILITY(U,$J,358.3,32167,2)
 ;;=^5015913
 ;;^UTILITY(U,$J,358.3,32168,0)
 ;;=N92.5^^126^1649^5
 ;;^UTILITY(U,$J,358.3,32168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32168,1,3,0)
 ;;=3^Irregular Menses,Oth Specified
 ;;^UTILITY(U,$J,358.3,32168,1,4,0)
 ;;=4^N92.5
 ;;^UTILITY(U,$J,358.3,32168,2)
 ;;=^5015912
 ;;^UTILITY(U,$J,358.3,32169,0)
 ;;=N92.0^^126^1649^6
 ;;^UTILITY(U,$J,358.3,32169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32169,1,3,0)
 ;;=3^Menorrhagia
 ;;^UTILITY(U,$J,358.3,32169,1,4,0)
 ;;=4^N92.0
 ;;^UTILITY(U,$J,358.3,32169,2)
 ;;=^5015908
 ;;^UTILITY(U,$J,358.3,32170,0)
 ;;=N91.5^^126^1649^7
 ;;^UTILITY(U,$J,358.3,32170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32170,1,3,0)
 ;;=3^Oligomenorrhea
 ;;^UTILITY(U,$J,358.3,32170,1,4,0)
 ;;=4^N91.5
 ;;^UTILITY(U,$J,358.3,32170,2)
 ;;=^5015907
 ;;^UTILITY(U,$J,358.3,32171,0)
 ;;=N93.0^^126^1649^8
 ;;^UTILITY(U,$J,358.3,32171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32171,1,3,0)
 ;;=3^Postcoital Bleeding
 ;;^UTILITY(U,$J,358.3,32171,1,4,0)
 ;;=4^N93.0
 ;;^UTILITY(U,$J,358.3,32171,2)
 ;;=^5015914
 ;;^UTILITY(U,$J,358.3,32172,0)
 ;;=N95.0^^126^1649^9
 ;;^UTILITY(U,$J,358.3,32172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32172,1,3,0)
 ;;=3^Postmenopausal Bleeding
 ;;^UTILITY(U,$J,358.3,32172,1,4,0)
 ;;=4^N95.0
 ;;^UTILITY(U,$J,358.3,32172,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,32173,0)
 ;;=N93.8^^126^1649^10
 ;;^UTILITY(U,$J,358.3,32173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32173,1,3,0)
 ;;=3^Uterine Bleed,Dysfuntional (DUB)
 ;;^UTILITY(U,$J,358.3,32173,1,4,0)
 ;;=4^N93.8
 ;;^UTILITY(U,$J,358.3,32173,2)
 ;;=^5015915
 ;;^UTILITY(U,$J,358.3,32174,0)
 ;;=C56.1^^126^1650^9
 ;;^UTILITY(U,$J,358.3,32174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32174,1,3,0)
 ;;=3^Ovarian CA,Right
 ;;^UTILITY(U,$J,358.3,32174,1,4,0)
 ;;=4^C56.1
 ;;^UTILITY(U,$J,358.3,32174,2)
 ;;=^5001212
 ;;^UTILITY(U,$J,358.3,32175,0)
 ;;=C56.2^^126^1650^8
 ;;^UTILITY(U,$J,358.3,32175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32175,1,3,0)
 ;;=3^Ovarian CA,Left
 ;;^UTILITY(U,$J,358.3,32175,1,4,0)
 ;;=4^C56.2
 ;;^UTILITY(U,$J,358.3,32175,2)
 ;;=^5001213
 ;;^UTILITY(U,$J,358.3,32176,0)
 ;;=N70.02^^126^1650^6
 ;;^UTILITY(U,$J,358.3,32176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32176,1,3,0)
 ;;=3^Oophoritis,Acute
 ;;^UTILITY(U,$J,358.3,32176,1,4,0)
 ;;=4^N70.02
 ;;^UTILITY(U,$J,358.3,32176,2)
 ;;=^5015803
 ;;^UTILITY(U,$J,358.3,32177,0)
 ;;=N70.03^^126^1650^14
 ;;^UTILITY(U,$J,358.3,32177,1,0)
 ;;=^358.31IA^4^2
